100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
Moxifloxacin Related Compound G (Hydrochloride Monohydrate)
● In Stock
| Catalogue No.: | VE006991 |
|---|---|
| CAS No.: | N/A |
| Mol. Formula: | C21H27ClFN3O5 |
| Mol. Weight: | 455.91 g/mol |
Additional information on Moxifloxacin Related Compound G (Hydrochloride Monohydrate)
Parent drug
MoxifloxacinIUPAC Name
1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aR, 7aR)-octahydro-6H-pyrrolo[3, 4-b]pyridin-6-yl]-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid hydrochloride monohydratePharmacopoeial Synonyms
N/AOther Synonyms
Moxifloxacin(R,R)-Isomer/ (4aR,7aR)-Moxifloxacin / ent-Moxifloxacin / d-Moxifloxacin(hydrochloride monohydrate)Smile
O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N(C4)CC5C4CCCN5)=C3OC)C1=O)O.[H]Cl.[H]O[H]InChI
InChI=1S/C21H24FN3O4.ClH.H2O/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H;1H2Description
Moxifloxacin Related Compound G (Hydrochloride Monohydrate) is a meticulously characterized reference material that complies with rigorous regulatory requirements, including those defined by USP, EMA, JP, and BP. This product plays a crucial role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Moxifloxacin. It is further supported by a detailed Structure Elucidation Report (SER), ensuring high accuracy and reliability across a broad range of analytical applications.”
Request a Quote
"*" indicates required fields
Other products related to Moxifloxacin impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
